Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 2.6/5
Frontage Holdings (1521 HK)
Watchlist
62
Analysis
Health Care
•
China
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hangzhou Tigermed Consulting C
•
06 Aug 2020 06:57
Tigermed IPO: Trading Debut
Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
Arun George
Follow
484 Views
Share
bullish
•
Hangzhou Tigermed Consulting C
•
27 Jul 2020 06:38
Tigermed IPO: Valuation Insights
Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
Arun George
Follow
505 Views
Share
bullish
•
Hangzhou Tigermed Consulting (A)
•
19 Jul 2020 17:00
Tigermed IPO: PHIP Highlights the Trade-Offs
Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
Arun George
Follow
461 Views
Share
bullish
•
Hangzhou Tigermed Consulting (A)
•
26 Apr 2020 12:49
Tigermed IPO Initiation: Trade-Offs
Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
Arun George
Follow
530 Views
Share
bullish
•
Hangzhou Tigermed Consulting (A)
•
26 Apr 2020 06:29
Tigermed (泰格医疗) A+H Listing: Hot Deal of the Best China Clinical-CRO Play
Hangzhou Tigermed is a leading China-based CRO company seeking a USD 1 bn H-share listing in Hong Kong. The company was listed on the A-share...
Ke Yan, CFA, FRM
Follow
602 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x